Massmedica S.A. (WSE:MSM)

Poland · Delayed Price · Currency is PLN

5.36

0.00 (0.00%)

Last updated: Oct 6, 2026, 4:15 PM CET

Market Cap	12.94M +44.9%
Revenue (ttm)	31.77M +8.7%
Net Income	618.27K +63.5%
EPS	0.26 +63.5%
Shares Out	2.41M
PE Ratio	20.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,423
Open	5.16
Previous Close	5.36
Day's Range	5.10 - 5.38
52-Week Range	3.26 - 7.50
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 16, 2026

About Massmedica

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It provides products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include supplements, skin care, sun protection, creams, tools, serum, masks, carboxytheraphy, and intra-articular injections. It also offers reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon li... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies

Founded 2011

Employees 14

Stock Exchange Warsaw Stock Exchange

Ticker Symbol MSM

Full Company Profile

Financial Performance

In 2025, Massmedica's revenue was 32.22 million, a decrease of -1.20% compared to the previous year's 32.61 million. Earnings were 535,808, a decrease of -11.23%.

Financial Statements